Nolvadex vs Testosterone for hormones
Short answer: For hormones, more users report improvement with Nolvadex — 97% of 37 reports, versus 91% of 101 for Testosterone.
Nolvadex has 6 meta-analyses and 22 randomized trials on PubMed; Testosterone has 75 and 125.
Based on 219 reports about Nolvadex and 922 about Testosterone. Not medical advice.
| Nolvadex Medication | Testosterone Medication | |
|---|---|---|
| User score | 45 | 53 |
| Verdict | Mostly positive | Mostly positive |
| Positive of reports that state an outcome | 67% | 78% |
| Reports | 219 | 922 |
| Research | AResearch: Strong | AResearch: Strong |
| Meta-analyses / RCTs | 6 / 22 | 75 / 125 |
| Mainly used for | ||
| Weight loss % reporting improvement | — | 94% (47) |
| Focus % reporting improvement | — | 83% (30) |
| Energy % reporting improvement | 100% (3) | 93% (88) |
| Sleep % reporting improvement | — | 79% (19) |
| Anxiety % reporting improvement | — | 80% (25) |
| Mood % reporting improvement | — | 89% (117) |
| Memory % reporting improvement | — | 100% (2) |
| Performance % reporting improvement | 50% (2) | 98% (179) |
| Recovery % reporting improvement | — | 92% (26) |
| Pain & inflammation % reporting improvement | — | 71% (7) |
| Libido % reporting improvement | 67% (3) | 90% (78) |
| Hormones % reporting improvement | 97% (37) | 91% (101) |
| Heart & lipids % reporting improvement | — | 56% (9) |
| Skin & hair % reporting improvement | — | 40% (5) |
| Longevity % reporting improvement | — | 67% (3) |
| Common side effects | fatigue, depression, mood swings, brain fog | suppression, hair loss, acne, water retention |
| Typical dose reported | 3 weeks at 10 mg daily | 200 mg / weekly |
The current debate is centered on whether the optimal strategy is to give an aromatase inhibitor initially or after several years of tamoxifen treatment. Multiple important questions remain, including the predictive value of molecular markers such as progesterone receptor, the optimal duration of aromatase inhibitor therapy, the long-term adverse effects, and the relative efficacy and toxicity of the different aromatase inhibitors.
Clin Cancer Res, 2006 ↗“This is now 2nd day on nolva and I swaer my balls are about back to normal. Energy is a bit better”
The guidelines also provide recommendations regarding identification of patients, dosing, monitoring, and follow-up. This Practice Pearl will discuss evidence-based testosterone therapy for management of HSDD in postmenopausal women.
Menopause, 2023 ↗“Feel the best I've ever felt in my life. TRT and peptides have been game changers for me!”
Related comparisons
Percentages come from first-hand user reports and are not clinical outcomes. Talk to a doctor before starting, stopping or combining anything. How we rate